Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback